Key Takeaways
- A weather-driven quarter, not a structural one: Consolidated revenue fell 4% YoY to ₹925 cr, almost entirely because a weak summer crushed the summer portfolio; domestic business excluding summer grew 11%.
- The summer bet is binary and back-loaded: Management is "very confident" of double-digit summer-brand growth in H1, but that confidence rests on a normal season that has not yet materialized, and BoroPlus remains explicitly unpredictable.
- Gross margins are the quiet strength: Expanded 250 bps YoY to 68.4% in Q4 and 130 bps for the full year, giving the P&L a cushion that operating deleverage has not yet erased.
- International is a Q2 story: Geopolitical disruption in the Middle East knocked international down 5% in Q4; April grew just ~2%, and management needs May/June stabilization before double-digit growth becomes credible from Q2.
- What to watch next quarter: Whether the summer portfolio actually delivers the promised double-digit rebound, whether international stabilizes on schedule, and whether the new Chief Growth Officer can sustain the 30%+ pace he has promised for the new and mainstream portfolio.
The Summer Portfolio: The Quarter's Central Risk
- The damage was concentrated: Summer portfolio declined 22% in Q4, with talcum powders alone down 40%, driven by a delayed and inconsistent summer plus unseasonal rainfall. Management was explicit that this was not structural or competitive weakness.
- The talc reset is large and lasting: Talc lost nearly ₹100 cr of revenue in FY26, falling from ₹400 cr to ₹300 cr. Part of that was a conscious receivables reduction of over ₹100 cr during the year, improving the working capital cycle by 10 days as part of distributor hygiene.
- The H1 bet: Management is "very confident" of double-digit growth for Navratna and Dermicool in the first half, and notes some spurt already visible in April and May. But BoroPlus, on a lower base, carries no such confidence: management says it is "impossible to say how the season pans out."
- Talc margin mix: The talc category carries slightly lower margins than other products, so a talc rebound would be a mixed blessing for the overall margin profile.
Mohan Goenka: "This decline was primarily driven by weak summer rather than any structural or competitive weakness in our business."
Domestic Ex-Summer: The Underlying Engine
- Core resilience: Domestic business excluding the summer portfolio grew 11% in Q4, reflecting strong brand equity and strategic execution beneath the weather noise. For the full year, excluding talc and summer, growth was around 5%.
- Hair oil momentum: Kesh King, 7 Oils in One, and Navratna have all performed well over the last two quarters after a weak H1. Management attributes this partly to unorganized trade becoming unviable due to disruptions and rising costs, driving a spurt in organized hair oil businesses, and partly to BCG strategy implementation. Momentum is continuing into the current quarter.
- Channel mix transformation: Organized channels now account for ~32% of domestic business, with wholesale dependency reduced to 27%. Quick Commerce grew 70% and GT Marts grew 25%. Margins in modern trade and e-commerce have improved significantly and are now quite close to general trade margins.
- Distribution focus: Current direct reach stands at 500,000 outlets across 100,000 towns. The focus is on urban India GT Marts and upgraded or premium stores, with efforts directed at improving reach through more lines and efficiencies rather than raw outlet expansion. Management declined to provide specific reach targets for the next 12 or 24 months.
International: Waiting for the Strait to Clear
- The disruption: International business declined 5% in Q4 due to geopolitical disruptions in the Middle East. The Strait of Hormuz supply chain shutdown from February 28 impacted shipping routes, supply chains, freight costs, and operations across GCC, Middle East, CIS, and South Asian markets.
- The recovery path: April delivered only ~2% growth. Management expects stabilization in May and June, with good double-digit growth from Q2 onward. Q1 is expected to remain close to single-digit growth.
- The conditionality: This timeline depends on geopolitical normalization in a region where Emami has no control over events, making the Q2 double-digit promise a forecast contingent on external stability.
Vivek Dhir: "Come April, we have been able to reset and we are almost like a little 2% growth in the month of April. So we are also expecting things to get stable in May and June as well. And from second quarter, we should be able to deliver good double-digit growth."
Strategic Investments: The Growth Optionality
- The Man Company: Seeing healthy traction across key categories, with strong growth in perfumes and non-gas deodorants, benefiting from digital-first channels.
- Axiom (beverages): Already profitable and value-accretive, marking Emami's entry into the fast-growing fruit juice category. A new CEO has joined from Dabur to lead the beverages company. Management describes the aloe vera-based fruit drink as "absolutely differentiated product" and is "extremely hopeful" about its profitability, with "strong plans" in place.
- IncNut (Vedix, SkinKraft): Very high gross margins with very modest EBITDA losses, reflecting continued investment in growth and customer acquisition. Management holds a very high long-term aspiration for this business over the next five years, sees opportunities to immediately improve efficiencies, and is confident of growth in specific spaces like international and Vedix.
- New and mainstream portfolio: Dhruv Aggarwal, the newly appointed Chief Growth Officer, is "pretty confident" of growing this portfolio 30% plus year-on-year. The intent is to sustain growth at 30% YoY while improving the bottom line, with an aim to increase absolute EBITDA by about ₹15 cr this year.
Dhruv Aggarwal: "I'm pretty confident of growing this 30% plus year-on-year."
Margins: Gross Strength, EBITDA Pressure, No Commitments
- Gross margin expansion: Gross margins expanded 250 bps YoY to 68.4% in Q4 and 130 bps to 69.9% for the full year, reflecting cost discipline and pricing actions.
- EBITDA decline: EBITDA fell 15% in Q4 and 6% for the full year to ₹964 cr, driven by operating deleverage. A&P spend rose 12%, partly driven by the Brillare launch of Rosemary oil shorts and associated budgets, while traditional brand ad spends were in line or slightly down.
- The margin outlook is deliberately non-committal: When asked whether consolidated EBITDA can return to the 26%–27% range, management declined to commit, citing ongoing input cost pressure from crude price behavior. Some improvement is expected, but the posture is "let's wait and see."
- Copra question deflected: An analyst asked whether falling copra prices could reverse the trend of organized players gaining share. Management declined to answer, stating they do not track copra prices because Emami does not use that input.
Mohan Goenka: "Let's wait and see, Harit, still there is some pressure as far as the input costs are concerned because you know how the crude is behaving, okay? So we will have to just wait and watch."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Summer brand growth | Double-digit growth for Navratna and Dermicool | First half FY27 |
| International recovery | Stabilization in May/June, then good double-digit growth from Q2; Q1 close to single-digit growth | Q2 FY27 onward |
| New and mainstream portfolio growth | 30%+ YoY growth | FY27 |
| Strategic investments EBITDA | Increase absolute EBITDA by ~₹15 cr | FY27 |
| Strategic investments revenue growth | Sustain 30% YoY growth while improving bottom line | FY27 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue | ₹925 cr, decline of 4% YoY |
| Domestic business ex-summer portfolio growth | 11% |
| Summer portfolio growth | -22%; talcum powders alone declined 40% |
| Gross margin | 68.4%, improvement of 250 bps YoY |
| EBITDA | ₹187 cr, declined 15% YoY |
| PAT | ₹143 cr, decline of 12% YoY |
| Advertising and promotional spends growth | 12% YoY |
| Full year FY26 revenue | ₹3,780 cr, decline of 1% YoY |
| Full year FY26 gross margin | 69.9%, expanded 130 bps YoY |
| Full year FY26 EBITDA | ₹964 cr, declined 6% YoY |
| Full year FY26 PAT | ₹775 cr, declined 4% YoY |
| International business growth | -5% YoY; prior to Feb 28 was growing at almost double-digit, April growth ~2% |
| Strategic investments growth | 34% YoY; intent to sustain growth at 30% YoY |
| Organized channels share of domestic business | ~32%, up from prior periods; wholesale channel reduced to 27% |
| Quick Commerce growth | 70% YoY |
| Talc revenue | ~₹300 cr, roughly 10% of total business; lost almost ₹100 cr of business in talc last year |
| Weighted average price increase | ~3% in last 1.5–2 months |
| Receivables reduction | Over ₹100 cr during the year, 10 days improvement in working capital cycle |